The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 30, 2024

Filed:

Sep. 03, 2020
Applicants:

Northwestern University, Evanston, IL (US);

Exicure, Inc., Skokie, IL (US);

Inventors:

Chad A. Mirkin, Wilmette, IL (US);

Sonbinh T. Nguyen, Evanston, IL (US);

Resham Singh Banga, Chicago, IL (US);

Natalia Chernyak, Evanston, IL (US);

Sergei Gryaznov, San Mateo, CA (US);

Aleksandar Radovic-Moreno, Evanston, IL (US);

Christopher Mader, Cambridge, MA (US);

Assignees:

NORTHWESTERN UNIVERSITY, Evanston, IL (US);

EXICURE, INC., Skokie, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/127 (2006.01); A61K 48/00 (2006.01); C12N 15/11 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
A61K 9/1271 (2013.01); A61K 9/127 (2013.01); A61K 9/1277 (2013.01); A61K 48/00 (2013.01); C12N 15/111 (2013.01); C12N 15/113 (2013.01); C12N 2310/11 (2013.01); C12N 2310/12 (2013.01); C12N 2310/14 (2013.01); C12N 2310/141 (2013.01); C12N 2320/32 (2013.01);
Abstract

Liposomes termed as small unilamellar vesicles (SUVs), can be synthesized in the 20-50 nm size range, but encounter challenges such as instability and aggregation leading to inter-particle fusion. This limits their use as a therapeutic delivery agent. Increasing the surface negative charge of SUVs, via the attachment of anionic entities such as DNA/RNA, increases the colloidal stability of these vesicles. Additionally, the dense spherical arrangement and radial orientation of nucleic acids exhibits unique chemical and biological properties, unlike their linear counterparts. These liposomal particles, are non-toxic and though anionic, can efficiently enter cells without the aid of ancillary cationic transfection agents in a non-immunogenic fashion. These exceptional properties allow their use as delivery agents for gene regulation in different therapies and offer an alternative platform to metal core spherical nucleic acids.


Find Patent Forward Citations

Loading…